The main objective of this study is to evaluate the efficacy and safety of 24 hours of
closed-loop glucose control compared with standard diabetes treatment, in patients with type
2 diabetes treated by non-insulin glucose-lowering medications. This group is being studied
as it is representative of patients with glucose dysregulation.
Phase:
N/A
Details
Lead Sponsor:
University of Cambridge
Collaborator:
Cambridge University Hospitals NHS Foundation Trust